Press release
The Adult Hemoglobinopathy Testing Market to thrive on wearables from 2018-2026, reaching US$ 420 Mn
The Adult Hemoglobinopathy Testing Market is bound to witness a CAGR of 3.9% and US$ 420 Mn between 2018-2026. The current scenario is such that technology is making inroads into the healthcare vertical, which is, in turn, reducing the cumbersome, in-person interactions with the caregiver. Telehealth is expected to outlive physical meetings in the forecast period. This would be the state of the healthcare vertical going forward.Hemoglobinopathy is a common hereditary disease, encompassing genetic disease of hemoglobin mostly in the form of thalassemia or structural hemoglobin variants. Underdeveloped countries of the Mediterranean region, Africa, and Southeast Asia have the highest occurrence of hemoglobinopathy disorders, especially sickle cell anemia and thalassemia. Growing awareness regarding hemoglobinopathy disorders coupled with various private and public initiatives is fueling the growth of the global adult hemoglobinopathy testing market.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/24142
According to the new report by Persistence Market Research (PMR), the global adult hemoglobinopathy testing market is estimated to slowly gain momentum in the coming years. In terms of revenue, during the forecast period 2018-2026, the global adult hemoglobinopathy testing market is anticipated to reach a valuation of US$ 420 Mn by 2026, expanding at a moderate 3.9% CAGR.
Experts at PMR have studied the growth trajectory of the global adult hemoglobinopathy testing market, with comprehensive insights on the performance of the various regional markets. Europe is anticipated to be the most lucrative region for the hemoglobinopathy testing market, owing to the growing population migration.
Company Profiles:
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Chromsystems Instruments & Chemicals GmbH
BioMedomics, Inc
CapitalBio Technology Inc
Overview
Trinity Biotech
Streck, Inc .
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/24142
Since, hemoglobinopathy diagnosis is a complex and expensive process, with long-tern therapies to correct the disorder, costs associated with adult hemoglobinopathy testing further increases. However, several insurance benefits from the Governments and inclusive reimbursement systems for diagnostic tests and treatments in the U.S and Europe, creates a favorable environment for the growth of the global hemoglobinopathy testing market. However, lack of awareness- about the disorder and the treatment among certain sections, especially in underdeveloped and developing economies, is a major factor restricting the growth of the global hemoglobinopathy testing market.
Key players in the global hemoglobinopathy testing market have been channelizing efforts towards development of new technologies such as HPLC tandem mass spectrometric (LC MS/MS) and point of care testing.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/24142
Increased Immigration of High-Risk Population Contributing to Adult Hemoglobinopathy Testing Adoption
The World Health Organization has identified Sickle Cell Anemia as a global health problem, mostly prevalent in African and sub-Asian regions. A large population, from the affected areas are migrating to Europe and North America, thereby increasing pool of newly diagnosed cases of hemoglobinopathy disorders. In the wake of increased migration, the adult hemoglobinopathy testing market is expected to swing up in northern and central Europe, particularly Germany.
Similarly, with increased migration from Asia, North America has witnessed an increase in the hemoglobinopathy detected cases, thereby, fueling the hemoglobinopathy testing market over the forecast period. In the lieu of increasingly hemoglobinopathy genotypes, policy makers have been implementing several public health interventions including screening programs and genetic testing and counselling, which will further drive the global adult hemoglobinopathy testing market in the coming year.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/adult-hemoglobinopathy-testing-market.asp
Genetic & Molecular Testing to Propel Adult Hemoglobinopathy Testing Market; Diagnostic Advancements to Present Investment Opportunities
Since hemoglobinopathy is a genetic cure, there is no permanent cure it. However, to fight that, government and non-government policy makers are continually rolling out advance testing methods for hemoglobinopathy diagnosis, especially in underdeveloped and developing economies more prone to hemoglobinopathy, creating an opportunity for prenatal diagnostic testing and molecular testing. Governments are developing adequate facilities for prenatal diagnosis along with establishments to manage existing hemoglobinopathy patients. Premarital and prenatal genetic testing for the sickle cell trait identification is rapidly gaining popularity in developed as well as developing countries.
Moreover, growing demand for rapid and accurate detection tests is expected to provide lucrative opportunities to new players in the adult hemoglobinopathy testing market coupled with research and development activities, further augmenting the adoption of hemoglobinopathy testing techniques. Lack of early and precise detection in Sub-Saharan African region results in early mortality in hemoglobinopathy patients. Low-cost therapies, rapid POC diagnosis methods, and collaboration with government and NGOs for more novel diagnostic methods are likely to present investment opportunities to manufacturers in the global hemoglobinopathy testing market.
Related Reports:
Urothelial Carcinoma Diagnostics Market - https://www.persistencemarketresearch.com/market-research/urothelial-carcinoma-diagnostics-market.asp
Immunoassay Interference Blocker Market - https://www.persistencemarketresearch.com/market-research/immunoassay-interference-blocker-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Adult Hemoglobinopathy Testing Market to thrive on wearables from 2018-2026, reaching US$ 420 Mn here
News-ID: 2681491 • Views: …
More Releases from Persistence Market Research
Libya Baby Diapers and Wipes Market Set to Reach US$ 392.2 Mn by 2033 Says Persi …
The Libya baby diapers and wipes market is projected to expand at a 4.5% compound annual growth rate (CAGR) from 2023 to 2033, reaching an estimated value of US$ 392.2 million by 2033. The market was valued at US$ 242.9 million at the end of 2022.
Request a Sample: https://www.persistencemarketresearch.com/samples/33030
Key Market Drivers
Several factors are underpinning the growth in the Libyan market for baby diapers and wipes:
• Growing awareness of infant hygiene: As…
Foodservice Packaging Market Worth 522.4 Billion by 2032 - Persistence Market Re …
The foodservice packaging market is undergoing significant transformation, driven by evolving consumer preferences, technological innovations, and rising sustainability demands. Foodservice packaging encompasses a wide range of products including containers, trays, cups, lids, bags, and cutlery used across quick-service restaurants, full-service dining, catering, and delivery platforms.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/22354
As global food consumption habits shift toward convenience and on-the-go…
BOPP for Labels Market to Reach US$ 31.2 Billion by 2032 with 6.1% CAGR, Reports …
The packaging and labelling industry has witnessed significant transformation over the past decade, with brands increasingly seeking materials that are cost-effective, durable, and visually appealing. One material that has gained substantial traction in this context is biaxially oriented polypropylene, commonly known as BOPP. BOPP films are widely recognized for their versatility, excellent printability, and resilience against moisture and chemicals. These characteristics make BOPP an ideal choice for labels across various…
Emulsion Explosives Market to Grow from US$ 2.57 Billion in 2024 to US$ 3.57 Bil …
The global emulsion explosive market has witnessed substantial growth over the past few years, driven by increasing demand from the mining, construction, and infrastructure sectors. Emulsion explosives are considered a safer, more efficient alternative to traditional blasting agents due to their improved performance, water resistance, and enhanced safety profile. Their adoption is growing steadily as industries seek higher productivity, better control, and environmentally safer solutions for blasting operations.
Get a Sample…
More Releases for Hemoglobinopathy
Hemoglobinopathy Treatment Market Future Prediction Report By 2032
The global Hemoglobinopathy Treatment market was valued at approximately USD 8.28 billion in 2022 and is projected to reach around USD 20.70 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.6% from 2023 to 2032.
The growth of the market is primarily attributed to a surge in the cases of hemoglobinopathies, as well as the public awareness of hemoglobin disorders. According to the World Health Organization, about 1.1%…
Hemoglobinopathy Treatment Advancements: Global Market Forecast 2024
"The Business Research Company recently released a comprehensive report on the Global Hemoglobinopathies Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The hemoglobinopathies treatment market size…
Empowering Lives: Exploring Breakthroughs in the Hemoglobinopathy Market
Hemoglobinopathy Market 2023
The health systems and data are moving to cloud. Healthcare vertical has several sprawling networks, inclusive of hospitals systems and universities, which could render an effective communication amongst doctor's offices, pharmacies, radiology labs, patients, health insurance companies, and likewise. Cloud-based platforms are actually making things like patient portals easily accessible along with interoperability. This would be the scene with XYZ market in the forecast period.
Get Free Sample Copy…
Hemoglobinopathy Market Industry Analysis - Hemoglobinopathy Market Size Driven …
The most recent study offered by Acumen Research and Consulting focuses Hemoglobinopathy Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Hemoglobinopathy Market trends in order to assess its current and future potential. Our Hemoglobinopathy Market analysis also provides market participants and new entrants with a comprehensive view of the…
The Hemoglobinopathy Market to grow through mobile apps
The Hemoglobinopathy Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent in…
Adult Hemoglobinopathy Testing Market See Incredible Growth During 2026
The worldwide market for adult hemoglobinopathy testing is anticipated to gradually gain momentum over the years to follow. In revenue terms, over the assessment time frame 2026, the worldwide market is estimated to account for a market evaluation of US$ XXX.X Million towards the end of 2026. The worldwide market is likely to expand at a X% CAGR all through the calculated period 2026.
Hemoglobinopathy is typically an inherited disease, incorporating…
